ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Mars and Pairwise Collaborate to Accelerate Cacao Research and Development

Durham, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mars, Incorporated has licensed Pairwise's Fulcrum® gene editing tools for cacao research and development. This licensing agreement grants Mars access to Pairwise's CRISPR tools, including the SHARC™ enzyme. The Pairwise Fulcrum platform encompasses gene editing tools, enzymes and trait libraries, enabling precise changes that unlock the plant’s inherent potential. This capability significantly accelerates the development of impactful crop traits compared to traditional breeding methods, allowing for the activation or deactivation of characteristics and fine-tuning traits, much like adjusting a dimmer switch to achieve optimal results.

Mars aims to develop this advanced plant breeding technology to improve cacao production and effectively tackle agricultural challenges. The ultimate goal is to help address the pressures cacao faces globally from climate variability, plant diseases and environmental stresses. This strategic initiative underscores the potential of this technology to drive meaningful advancements in agriculture.

"At Mars, we believe CRISPR has the potential to improve crops in ways that support and strengthen global supply chains," said Carl Jones, Plant Sciences Director at Mars. "Our focus is to transparently and responsibly conduct CRISPR research in plant science that helps crops better adapt to climate challenges, disease pressures and resource constraints."

"We're pleased to provide Mars with access to our Fulcrum platform for their cacao research and development initiatives," said Ian Miller, Chief Operating Officer at Pairwise. "Plant breeding innovation has the potential to help address important agricultural challenges, and we look forward to supporting Mars' research goals."

The Pairwise Fulcrum platform includes gene editing tools, enzymes and trait libraries, enabling precise changes that unlock the plant’s inherent potential to greatly accelerate the development of impactful crop traits compared to traditional breeding methods.

###

About Pairwise 

Pairwise is agriculture’s gene editing powerhouse, building a healthier world through partnership and plant innovation. Co-founded by the inventors of CRISPR, our Fulcrum® Platform accelerates the development of climate-resilient, nutritious, and sustainable crops. As trusted partners to global industry leaders and nonprofit institutions, we help breeders move faster while transforming food and agriculture for farmers, consumers, and the planet. Founded in 2017 and based in Durham, NC, Pairwise is committed to delivering innovation that makes food easier to grow and better to eat. For more information, visit www.pairwise.com


Communications
Pairwise
communications@pairwise.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.